tiprankstipranks
Recordati Industria Chimica e Farmaceutica SPA (MX:RECN)
LSE:RECN
Mexico Market
RECN
Recordati Industria Chimica e Farmaceutica SPA
RESEARCH TOOLSreports

Recordati Industria Chimica e Farmaceutica SPA (RECN) Ratios

― Followers

Recordati Industria Chimica e Farmaceutica SPA Ratios

MX:RECN's free cash flow for Q2 2026 was €0.71. For the 2026 fiscal year, MX:RECN's free cash flow was decreased by € and operating cash flow was €0.29. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.26 1.59 1.61 1.20 1.28
Quick Ratio
 0.86 1.08 1.06 0.79 0.82
Cash Ratio
 0.28 0.41 0.35 0.22 0.31
Solvency Ratio
 0.22 0.20 0.18 0.21 0.18
Operating Cash Flow Ratio
 0.46 0.57 0.61 0.48 0.50
Short-Term Operating Cash Flow Coverage
 1.04 1.77 1.87 4.86 1.21
Net Current Asset Value
€ -1.48B€ -1.65B€ -1.77B€ -1.32B€ -1.27B
Leverage Ratios
Debt-to-Assets Ratio
 0.43 0.47 0.48 0.35 0.43
Debt-to-Equity Ratio
 1.08 1.29 1.33 0.87 1.11
Debt-to-Capital Ratio
 0.52 0.56 0.57 0.46 0.53
Long-Term Debt-to-Capital Ratio
 0.44 0.52 0.53 0.44 0.46
Financial Leverage Ratio
 2.52 2.74 2.74 2.50 2.59
Debt Service Coverage Ratio
 1.15 1.72 1.72 3.48 1.13
Interest Coverage Ratio
 8.13 7.25 7.83 7.49 13.54
Debt to Market Cap
 0.22 0.24 0.23 0.14 0.21
Interest Debt Per Share
 11.85 12.49 12.46 7.48 8.51
Net Debt to EBITDA
 1.94 2.30 2.73 1.75 2.56
Profitability Margins
Gross Profit Margin
70.74%68.27%68.34%68.32%69.42%
EBIT Margin
28.86%25.99%26.83%27.16%23.40%
EBITDA Margin
36.63%33.88%33.97%34.01%30.18%
Operating Profit Margin
30.46%27.49%27.29%26.80%23.60%
Pretax Profit Margin
24.35%22.20%23.37%23.58%21.66%
Net Profit Margin
18.38%16.94%17.79%18.69%16.85%
Continuous Operations Profit Margin
18.38%16.94%17.79%18.69%16.85%
Net Income Per EBT
75.46%76.32%76.12%79.26%77.80%
EBT Per EBIT
79.94%80.76%85.64%88.00%91.79%
Return on Assets (ROA)
9.26%8.45%8.11%9.25%7.81%
Return on Equity (ROE)
24.74%23.11%22.19%23.08%20.20%
Return on Capital Employed (ROCE)
20.76%17.14%15.19%17.41%14.22%
Return on Invested Capital (ROIC)
13.55%12.11%10.76%13.34%9.81%
Return on Tangible Assets
23.00%21.50%22.83%26.09%21.38%
Earnings Yield
4.72%4.45%3.99%3.86%3.92%
Efficiency Ratios
Receivables Turnover
 3.47 4.44 4.53 4.68 4.95
Payables Turnover
 2.46 2.41 2.50 2.50 2.52
Inventory Turnover
 1.44 1.54 1.46 1.63 1.34
Fixed Asset Turnover
 11.72 11.78 11.33 11.66 11.64
Asset Turnover
 0.50 0.50 0.46 0.49 0.46
Working Capital Turnover Ratio
 7.53 4.41 6.15 9.02 7.63
Cash Conversion Cycle
 210.75 167.77 183.83 155.97 202.20
Days of Sales Outstanding
 105.06 82.25 80.55 78.04 73.80
Days of Inventory Outstanding
 253.80 237.18 249.37 223.98 273.12
Days of Payables Outstanding
 148.11 151.67 146.09 146.05 144.72
Operating Cycle
 358.86 319.44 329.92 302.02 346.92
Cash Flow Ratios
Operating Cash Flow Per Share
 3.17 2.90 2.76 2.36 2.25
Free Cash Flow Per Share
 2.86 2.49 2.59 0.50 1.78
CapEx Per Share
 0.31 0.41 0.18 1.86 0.47
Free Cash Flow to Operating Cash Flow
 0.90 0.86 0.94 0.21 0.79
Dividend Paid and CapEx Coverage Ratio
 1.92 1.69 1.96 0.77 1.41
Capital Expenditure Coverage Ratio
 10.26 7.01 15.55 1.27 4.79
Operating Cash Flow Coverage Ratio
 0.28 0.24 0.23 0.33 0.27
Operating Cash Flow to Sales Ratio
 0.24 0.23 0.24 0.23 0.25
Free Cash Flow Yield
5.52%5.13%5.13%1.01%4.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 21.32 22.47 25.05 25.89 25.51
Price-to-Sales (P/S) Ratio
 3.90 3.81 4.46 4.84 4.30
Price-to-Book (P/B) Ratio
 4.95 5.20 5.56 5.97 5.15
Price-to-Free Cash Flow (P/FCF) Ratio
 18.11 19.49 19.51 98.73 21.80
Price-to-Operating Cash Flow Ratio
 16.34 16.71 18.32 20.76 17.25
Price-to-Earnings Growth (PEG) Ratio
 0.94 3.24 3.64 1.06 -1.36
Price-to-Fair Value
 4.95 5.20 5.56 5.97 5.15
Enterprise Value Multiple
 12.57 13.54 15.85 15.98 16.80
Enterprise Value
 12.46B 12.01B 12.61B 11.32B 9.40B
EV to EBITDA
 12.57 13.54 15.85 15.98 16.80
EV to Sales
 4.60 4.59 5.38 5.44 5.07
EV to Free Cash Flow
 21.41 23.47 23.56 110.90 25.72
EV to Operating Cash Flow
 19.32 20.13 22.12 23.32 20.36
Tangible Book Value Per Share
 -5.29 -6.18 -6.95 -5.01 -4.83
Shareholders’ Equity Per Share
 10.47 9.34 9.10 8.20 7.52
Tax and Other Ratios
Effective Tax Rate
 0.25 0.24 0.24 0.21 0.22
Revenue Per Share
 13.30 12.74 11.35 10.13 9.01
Net Income Per Share
 2.44 2.16 2.02 1.89 1.52
Tax Burden
 0.75 0.76 0.76 0.79 0.78
Interest Burden
 0.84 0.85 0.87 0.87 0.93
Research & Development to Revenue
 0.13 0.13 0.12 0.12 0.12
SG&A to Revenue
 0.28 0.28 0.28 0.06 0.06
Stock-Based Compensation to Revenue
 0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.30 1.35 1.37 1.25 1.48
Currency in EUR